Janney Montgomery Scott’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-21,688
Closed -$191K 2758
2024
Q2
$191K Sell
21,688
-119,223
-85% -$1.05M ﹤0.01% 2460
2024
Q1
$1.66M Sell
140,911
-22,648
-14% -$266K ﹤0.01% 1244
2023
Q4
$1.84M Sell
163,559
-93,328
-36% -$1.05M 0.01% 1141
2023
Q3
$1.74M Buy
256,887
+32,482
+14% +$220K 0.01% 1078
2023
Q2
$2.04M Sell
224,405
-15,043
-6% -$137K 0.01% 1054
2023
Q1
$1.55M Buy
239,448
+14,869
+7% +$96.1K 0.01% 1096
2022
Q4
$1.42M Buy
224,579
+29,093
+15% +$184K 0.01% 1184
2022
Q3
$1.21M Sell
195,486
-15,832
-7% -$98.2K 0.01% 1224
2022
Q2
$1.73M Sell
211,318
-49,392
-19% -$404K 0.01% 997
2022
Q1
$2.2M Buy
260,710
+146,796
+129% +$1.24M 0.01% 880
2021
Q4
$1.16M Buy
113,914
+14,591
+15% +$149K ﹤0.01% 1243
2021
Q3
$1.93M Buy
99,323
+41,983
+73% +$815K 0.01% 971
2021
Q2
$1.01M Buy
+57,340
New +$1.01M ﹤0.01% 1266